Health Insurance Coverage for Asymptomatic Seborrheic Keratoses Treatment

Seborrheic keratosis is one of the most common benign cutaneous neoplasms encountered in dermatology practice. However, treatment of asymptomatic seborrheic keratosis is not covered by health insurance. Patients frequently report being bothered by the lesions but decline treatment to avoid incurring...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Eseosa, Dao, Harry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475156/
https://www.ncbi.nlm.nih.gov/pubmed/37667709
http://dx.doi.org/10.7759/cureus.42932
_version_ 1785100661423079424
author Fernandes, Eseosa
Dao, Harry
author_facet Fernandes, Eseosa
Dao, Harry
author_sort Fernandes, Eseosa
collection PubMed
description Seborrheic keratosis is one of the most common benign cutaneous neoplasms encountered in dermatology practice. However, treatment of asymptomatic seborrheic keratosis is not covered by health insurance. Patients frequently report being bothered by the lesions but decline treatment to avoid incurring “out of pocket” expenses. In this commentary, the authors explore the various conundrums associated with this and the implications for health equity and ethical medical financing.
format Online
Article
Text
id pubmed-10475156
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-104751562023-09-04 Health Insurance Coverage for Asymptomatic Seborrheic Keratoses Treatment Fernandes, Eseosa Dao, Harry Cureus Dermatology Seborrheic keratosis is one of the most common benign cutaneous neoplasms encountered in dermatology practice. However, treatment of asymptomatic seborrheic keratosis is not covered by health insurance. Patients frequently report being bothered by the lesions but decline treatment to avoid incurring “out of pocket” expenses. In this commentary, the authors explore the various conundrums associated with this and the implications for health equity and ethical medical financing. Cureus 2023-08-04 /pmc/articles/PMC10475156/ /pubmed/37667709 http://dx.doi.org/10.7759/cureus.42932 Text en Copyright © 2023, Fernandes et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Fernandes, Eseosa
Dao, Harry
Health Insurance Coverage for Asymptomatic Seborrheic Keratoses Treatment
title Health Insurance Coverage for Asymptomatic Seborrheic Keratoses Treatment
title_full Health Insurance Coverage for Asymptomatic Seborrheic Keratoses Treatment
title_fullStr Health Insurance Coverage for Asymptomatic Seborrheic Keratoses Treatment
title_full_unstemmed Health Insurance Coverage for Asymptomatic Seborrheic Keratoses Treatment
title_short Health Insurance Coverage for Asymptomatic Seborrheic Keratoses Treatment
title_sort health insurance coverage for asymptomatic seborrheic keratoses treatment
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475156/
https://www.ncbi.nlm.nih.gov/pubmed/37667709
http://dx.doi.org/10.7759/cureus.42932
work_keys_str_mv AT fernandeseseosa healthinsurancecoverageforasymptomaticseborrheickeratosestreatment
AT daoharry healthinsurancecoverageforasymptomaticseborrheickeratosestreatment

Ejemplares similares